• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Amount of co-transplanted donor-derived leukocytes determines in-vivo microchimerism and mixed lymphocyte culture changes post-liver transplantation.

作者信息

Weber S, Salguero R, Allers C, Blaheta R A, Markus B H

机构信息

Klinik für Allgemein- und Gefässchirurgie, Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main.

出版信息

Zentralbl Chir. 2003 Apr;128(4):278-82. doi: 10.1055/s-2003-38790.

DOI:10.1055/s-2003-38790
PMID:12700983
Abstract

OBJECTIVE

To evaluate the impact of passenger leukocytes in liver grafts on the rate of microchimerism induction after liver transplantation and to evaluate immunological changes thereafter based on serial donor-specific MLC's in these patients.

METHODS

26 orthotopic liver transplant recipients were prospectively evaluated for immunological changes based on the co-transplantation of donor-derived leukocytes. Intraoperatively harvested liver biopsies and peripheral blood-lymphocytes of liver transplant recipients were sampled at various time points. Donor spleen cells were obtained during organ procurement.

RESULTS

HLA-PCR analysis demonstrated a stable pattern of microchimerism in 15 out of 26 patients. Microchimerism was detectable by PCR up to a mean of 7 weeks after transplantation, when chimerism in the peripheral blood became negative. Passenger donor leukocytes were present in all biopsies obtained during backtable preparation of the liver graft. For the 15 patients presenting microchimerism the rate of passenger leukocytes in the liver graft biopsies showed a mean of 155.8 leukocytes per mm 2 liver tissue (SD +/- 23.2 cells/mm2, range 121 to 217 cells per mm2 tissue). Otherwise patients without chimerism showed a mean of 90.4 passenger leukocytes per mm2 tissue (SD +/- 14.5 cells/mm2, range: 52 to 99 cells/mm2). Lymphocyte proliferation, determined by donor-specific "multiple" single-way- mixed-lymphocyte-cultures (dsmMLC) was reduced to a mean of 62.2 % of preoperative values (SD +/- 14.5 %, range 33 % to 88 %) in the 15 patients with stable microchimerism. Otherwise in the 11 patients without microchimerism dsmMLC results stayed at continuously higher levels with a mean of 106 % (SD +/- 13.4, range 92 % to 134 %).

CONCLUSIONS

The results from these studies of microchimerism and lymphocyte reactivity after liver transplantation suggest that the co-transplantation of donor leukocytes plays an important and active role in the modulation of the host-immune system.

摘要

相似文献

1
Amount of co-transplanted donor-derived leukocytes determines in-vivo microchimerism and mixed lymphocyte culture changes post-liver transplantation.
Zentralbl Chir. 2003 Apr;128(4):278-82. doi: 10.1055/s-2003-38790.
2
Development of microchimerism in pediatric patients after living-related liver transplantation.亲属活体肝移植术后小儿患者微嵌合体的发展
Clin Transplant. 1997 Jun;11(3):193-200.
3
Development of donor-specific microchimerism in liver transplant recipient with HLA-DRB1 and -DQB1 mismatch related to rejection episodes.肝移植受者中与排斥反应相关的HLA-DRB1和-DQB1错配导致供体特异性微嵌合体的发展。
Transplant Proc. 2004 May;36(4):953-5. doi: 10.1016/j.transproceed.2004.03.097.
4
Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.监测全身供体淋巴细胞大嵌合体以辅助诊断肝移植后的移植物抗宿主病。
Transplantation. 2004 Feb 15;77(3):441-6. doi: 10.1097/01.TP.0000103721.29729.FE.
5
Donor type microchimerism is an infrequent event following liver transplantation and is not associated with graft acceptance.
Hepatology. 1997 Oct;26(4):848-52. doi: 10.1053/jhep.1997.v26.pm0009328303.
6
Microchimerism after liver transplantation: absence of rejection without abrogation of anti-donor cytotoxic T-lymphocyte-mediated alloreactivity.
Liver Transpl. 2005 Mar;11(3):290-7. doi: 10.1002/lt.20360.
7
Assessment of microchimerism in rat liver transplantation by polymerase chain reaction.
Hepatology. 1996 Apr;23(4):828-34. doi: 10.1053/jhep.1996.v23.pm0008666338.
8
Molecular mechanisms associated with donor-specific microchimerism in peripheral blood of Brazilian patients after liver transplantation.巴西患者肝移植后外周血中供体特异性微嵌合体相关的分子机制
Transplant Proc. 2006 Jun;38(5):1411-7. doi: 10.1016/j.transproceed.2006.02.058.
9
Macrochimerism of donor type CD56+ CD3+ T cells in donor specific transfusion via portal vein following living related donor liver transplantation.活体亲属供肝移植后经门静脉进行供体特异性输血时供体型CD56+ CD3+ T细胞的巨嵌合现象。
Hepatogastroenterology. 2003 Nov-Dec;50(54):2161-5.
10
Prospective analysis between the therapy of immunosuppressive medication and allogeneic microchimerism after liver transplantation.
Transpl Immunol. 2009 Jan;20(3):195-8. doi: 10.1016/j.trim.2008.08.009. Epub 2008 Oct 5.

引用本文的文献

1
Strategies for Liver Transplantation Tolerance.肝移植耐受的策略。
Int J Mol Sci. 2021 Feb 24;22(5):2253. doi: 10.3390/ijms22052253.
2
Neutropenia in type Ib glycogen storage disease.Ib 型糖原贮积病中的中性粒细胞减少症。
Curr Opin Hematol. 2010 Jan;17(1):36-42. doi: 10.1097/MOH.0b013e328331df85.
3
Improved neutrophil function in a glycogen storage disease type 1b patient after liver transplantation.肝移植后1b型糖原贮积病患者中性粒细胞功能改善。
Eur J Pediatr. 2004 Apr;163(4-5):202-6. doi: 10.1007/s00431-004-1405-1. Epub 2004 Feb 11.